National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 43096-43097 [2012-17791]
Download as PDF
<![CDATA[
43096
Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: July 16, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant application and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
application, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Diabetes Mellitus Interagency
Coordinating Committee Meeting
BILLING CODE 4140–01–P
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; The Contraceptive
Clinical Trials Network Statistical and
Clinical Coordinating Center (SCCC).
Date: August 6, 2012.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health, and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Jkt 226001
[FR Doc. 2012–17794 Filed 7–20–12; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
19:21 Jul 20, 2012
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–17795 Filed 7–20–12; 8:45 am]
VerDate Mar<15>2010
Dated: July 16, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Donald Compton:
Connections Among Reading
Comprehension, Math Problem Solving and
Working Memory.
Date: August 15, 2012.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, 5B01, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6911, hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: July 16, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–17792 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
National Institutes of Health
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on August
16, 2012, from 9:30 to 11:30 a.m. at 31
Center Drive on the NIH campus,
Building 31C, Conference Room 6. The
meeting is open to the public.
DATES: August 16, 2012, from 9:30 to
11:30 a.m.
ADDRESSES: National Institutes of
Health, 31 Center Drive, Building 31C,
Conference Room 6C, Bethesda, MD
20892.
SUMMARY:
For
further information concerning this
meeting, see the DMICC Web site,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; Fax:
301–480–6741; email:
dmicc@mail.nih.gov.
FOR FURTHER INFORMATION CONTACT:
The
DMICC facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
members to learn about and discuss
current and future diabetes programs in
DMICC member organizations and to
identify opportunities for collaboration.
The August 16, 2012, DMICC meeting
will focus on ‘‘Diabetes, Dementia, and
Alzheimer’s Disease.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23JYN1.SGM
23JYN1
Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
Web site, www.diabetescommittee.gov.
Dated: July 17, 2012.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2012–17791 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Targeting Persistent HIV
Reservoirs.
Date: August 15, 2012.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Jay R Radke, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, Room
2217, 6700B Rockledge Drive MDS–7616,
Bethesda, MD 20892–7616, 301–496–2550,
jay.radke@nih.gov.
VerDate Mar<15>2010
19:21 Jul 20, 2012
Jkt 226001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 13, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–17786 Filed 7–20–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NEURO–QOL Interim
Sustainability and Training.
Date: July 26, 2012.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health
(NINDS), NSC, 6001 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Phillip F. Wiethorn,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892,
301–496–5388, wiethorp@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
and limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Frm 00053
Fmt 4703
Dated: July 17, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–17909 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
PO 00000
43097
Sfmt 9990
National Eye Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Epidemiology
Applications.
Date: August 13, 2012.
Time: 11:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Anne E. Schaffner, Ph.D.,
Chief, Scientific Review Branch, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
Lane, Suite 1300, MSC 9300, 301–451–2020,
aes@nei.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI K99 Review.
Date: August 15, 2012.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call), Contact Person:
Brian Hoshaw, Ph.D., Scientific Review
Officer, Division of Extramural Research,
National Eye Institute, National Institutes of
Health, 5635 Fishers Lane, Suite 1300, MSC
9300, 301–451–2020, hoshawb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: July 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–17801 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 77, Number 141 (Monday, July 23, 2012)]
[Notices]
[Pages 43096-43097]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17791]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on August 16, 2012, from 9:30 to 11:30 a.m.
at 31 Center Drive on the NIH campus, Building 31C, Conference Room 6.
The meeting is open to the public.
DATES: August 16, 2012, from 9:30 to 11:30 a.m.
ADDRESSES: National Institutes of Health, 31 Center Drive, Building
31C, Conference Room 6C, Bethesda, MD 20892.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes
Mellitus Interagency Coordinating Committee, National Institute of
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; Fax: 301-480-6741; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The DMICC facilitates cooperation,
communication, and collaboration on diabetes among government entities.
DMICC meetings, held several times a year, provide an opportunity for
members to learn about and discuss current and future diabetes programs
in DMICC member organizations and to identify opportunities for
collaboration. The August 16, 2012, DMICC meeting will focus on
``Diabetes, Dementia, and Alzheimer's Disease.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written
[[Page 43097]]
comments with the Committee by forwarding their statement to the
contact person listed on this notice. The statement should include the
name, address, telephone number and when applicable, the business or
professional affiliation of the interested person. Because of time
constraints for the meeting, oral comments will be allowed on a first-
come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC Web site, www.diabetescommittee.gov.
Dated: July 17, 2012.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2012-17791 Filed 7-20-12; 8:45 am]
BILLING CODE 4140-01-P
